Anti-SARS-CoV-2 neutralizing monoclonal antibodies: clinical pipeline

• Main Authors: Marco Tuccori (Author), Sara Ferraro (Author), Irma Convertino (Author), Emiliano Cappello (Author), Giulia Valdiserra (Author), Corrado Blandizzi (Author), Fabrizio Maggi (Author), Daniele Focosi (Author)
• Format: Book
• Published: Taylor & Francis Group, 2020-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Monoclonal antibody (mAb) therapy has been previously exploited for viral infections, such as respiratory syncytial virus pneumonia and Ebolavirus disease. In the ongoing COVID-19 pandemic, early signals of efficacy from convalescent plasma therapy have encouraged research and development of anti-SA...